EVALUATING THE IMPACT OF DOXYCYCLINE GEL WITH ZINC OXIDE FOR TREATMENT OF MODERATE ACNE VULGARIS: A RANDOMIZED CONTROLLED TRIAL
Main Article Content
Keywords
Acne Vulgaris, doxycycline gel, zinc oxide gel, Topical Therapy, Randomized trial
Abstract
Background Acne vulgaris, commonly known as acne, is a chronic skin condition characterized by the occurrence of comedones , papules, pustules and sometimes cysts with nodules. It primarily affects adolescents and young adults, but can persist into adulthood.
Objective: To evaluate the efficacy of doxycycline gel versus zinc oxide in the treatment of moderate acne vulgaris at tertiary care Hospital, Karachi.
Study design: Randomized controlled trial.
Place and duration of study: This study was conducted at Department of Dermatology, Dow university hospital, Karachi from November 2023 till February 2024.
Methodology: Data was prospectively collected from patients after taking consent. The sample size for the study was 100 patients, 50 in each group (A- doxycycline gel and B- zinc oxide gel) were included. Patients presenting with moderate acne vulgaris in either group were assessed for degree of improvement using Global Acne Grading Scale and patients achieving a score of ≤ 18 after 12 weeks of treatment was labeled as efficacy. Data was analyzed on SPSS Version 22.
Results: The study involved participants aged 20-70 years with Group A (mean age 24.20±5.99) and Group B (mean age 26.221±6.50). In both groups, predominantly there were females, majority in the 20- 49 age range. Efficacy was significantly higher in Group B (82%) compared to Group A (12%). Stratification by gender, and age revealed substantial differences in efficacy, particularly for participants with acne duration ≤ 3 months.
Conclusion: The outcome of this study demonstrates that zinc oxide gel had better efficacious results compared to the doxycycline gel monotherapy after 12 weeks of treatment.
References
2. Adebamowo C.A., Spiegelman D., Danby F.W., Frazier A.L., Willett W.C., Holmes M.D. High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2019;52(2):207–14
3. Agarwal US, Besarwal RK, Bhola K. Doxycycline in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol. 2021;77(6):688– 94.
4. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne withzinc supplements: a randomized, controlled multicenter study. Arch Dermatol Res. 2017;299(10):467–73.
5. Zhu YI, Stiller MJ. Zinc oxide geland sulfones in dermatology: overview and update. J Am Acad Dermatol. 2021;45(3):420‒434.
6. Ross CM. The treatment of acne vulgaris with zinc supplements. Br J Dermatol. 1961;73:367‒70.
7. Czemielewski J, Michel S, Bouclier M, et al. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2021;15(3):5‒12.
8. Nast A, Dreno B, Bettoli V, et al. European evidence-based (s3) guidelines for the treatment of acne-update 2016 short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261‒68.
9. Lynde CW, Andriessen A. Cohort study on the treatment with zinc oxide gel of mild to moderate inflammatory acne of the face in women. Skinmed. 2024;12(1):15‒21.
10. Taghetti E, Harper JC, Oefelein MG. The efficacy and tolerability of doxycycline gel in female Vs males patients with facial and vulgaris, gender as a clinically relevant outcome variable. J Drug Dermatol. 2022;11(12):1417‒21.
11. Brar BK, Kumar S, Sethi N. Comparative evaluation of Isotretinion vs. doxycycline 1% gel in mild to moderate acne vulgaris. Gulf J Dermatol Venereol. 2017;23(1):34-9.
12. Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. J Dermatol Venereol Leprol 2009;75:323.
13. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries :A systematic analysis for the global burden of disease study 2020. Lancet 2012;380:2163-96.
14. Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol 2018;4:56-71.
15. Katsambas A, Towarky AA, Stratigos J. Topical doxycycline phosphate compared with oral doxycycline in the treatment of acne vulgaris. Br J Dermatol 1987;116:387-91.
16. Shalita AR, Smith EB, Bauer E. Topical erythromycin v doxycycline therapy for acne: A multicenter, double-blind comparison. Arch Dermatol 1984;120:351-5.
17. Chu A, Huber FJ, Plott RT. The comparative efficacy of doxycycline
18. and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol 1997;136:235-8.
19. Drucker CR. Update on topical antibiotics in dermatology. Dermatol Ther 2012;25:6‐11.
20. Worret WI, Fluhr JW. Topische Therapie mit Benzoylperoxid, Antibiotika und Azelainsäurebei der Akne (Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid). J Dtsch Dermatol Ges 2006;4:293‐300.
21. Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: A review. J Drugs Dermatol 2010;9:655‐64.
22. Guin JD, Reynolds R, Gielerak PL. Penetration of topical doxycycline into comedones. J Am Acad Dermatol 1980;3:153-6.
23. Tan J. Zinc oxide gel: A new option in topical therapy for acne. Skin Ther Lett 2022;17:1-3.
24. Verma R, Yadav P, Chudhari M, Patel J, Umrigar D. Comparison of efficacy of two topical drug therapy of acne vulgaris–1% doxycycline with erythromycin: A split face comparative study. National Journal of Physiology, Pharmacy and Pharmacology. 2022;12(6):817-2
